Clinical Trials in Austin

Showing 7641-7660 of 15,205 trials

Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris

NCT03915860

Participant Reported Outcomes with use of Trifarotene 50 μg/g Cream in participants with Moderate Facial and Truncal Acne Vulgaris

Acne Vulgaris

Galderma R&D47 participantsStarted Mar 2019

Fort Smith, Arkansas, United States • Beverly, Massachusetts, United States • Portsmouth, New Hampshire, United States +6 more locations

COMPLETEDPhase 1< 1 mile

A Phase 1 TP-271 Oral PK Single Ascending Dose Study

NCT03024034

The purpose of this study is to determine the safety and tolerability of up to 6 different single ascending oral doses of TP-271, ranging from 25 mg to 300 mg, in healthy adult male or female subjects.

Bacterial Infections

Tetraphase Pharmaceuticals, Inc56 participantsStarted Mar 2017

Austin, Texas, United States

COMPLETEDPhase 1< 1 mile

A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271

NCT02724085

This is a single-center, randomized, placebo-controlled, double-blind, single-ascending-dose, inpatient study to assess the safety, tolerability, and pharmacokinetics of TP-271 in healthy subjects. Subjects aged 18 to 50 years who fulfill the inclusion/exclusion criteria will be enrolled in this study.

Pneumonia

Tetraphase Pharmaceuticals, Inc57 participantsStarted Dec 2015

Austin, Texas, United States

Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris

A Phase 1 TP-271 Oral PK Single Ascending Dose Study

A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271

Find Trials by Condition in Austin

A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease

Assessment of LBR-101 In Chronic Migraine

Study of INCB053914 in Subjects With Advanced Malignancies

Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)

Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer

Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)

A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD)

Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics

A Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy

Restore EF Observational Study

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors

A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies

Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer

A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL)

Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine